世界のペニシリン/ストレプトマイシン市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV08811)
◆英語タイトル:Global Penicillin/Streptomycin Market Insights and Forecast to 2026
◆商品コード:QYR20NV08811
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:153
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはペニシリン/ストレプトマイシンの世界市場について調査・分析した資料です。種類別(ペニシリン、ストレプトマイシン)の市場規模、用途別(病院、診療所、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別ペニシリン/ストレプトマイシンの競争状況、市場シェア
・世界のペニシリン/ストレプトマイシン市場:種類別市場規模 2015年-2020年(ペニシリン、ストレプトマイシン)
・世界のペニシリン/ストレプトマイシン市場:種類別市場規模予測 2021年-2026年(ペニシリン、ストレプトマイシン)
・世界のペニシリン/ストレプトマイシン市場:用途別市場規模 2015年-2020年(病院、診療所、その他)
・世界のペニシリン/ストレプトマイシン市場:用途別市場規模予測 2021年-2026年(病院、診療所、その他)
・北米のペニシリン/ストレプトマイシン市場分析:米国、カナダ
・ヨーロッパのペニシリン/ストレプトマイシン市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのペニシリン/ストレプトマイシン市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のペニシリン/ストレプトマイシン市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのペニシリン/ストレプトマイシン市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Johnson & Johnson、Pfizer、Bayer HealthCare、Abbot Laboratories、Roche Pharmaceuticals、Sanofi Aventis、Takeda Pharmaceutical Company、Toyama Chemical、Merck & Co.、MiddleBrook Pharmaceuticals、Novartis、Biogen IDEC、Bristol Myers Squibb、Celgine Corporation、Eli Lilly and Co、Gilead Sciences、GlaxoSmithKline、Amgen、Astellas Pharma、Astra Zeneca
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Penicillin/Streptomycin Market
The global Penicillin/Streptomycin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Penicillin/Streptomycin Scope and Market Size
Penicillin/Streptomycin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Penicillin/Streptomycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Penicillin/Streptomycin market is segmented into
Penicillin
Streptomycin

Segment by Application, the Penicillin/Streptomycin market is segmented into
Hospitals
Clinics
Others

Regional and Country-level Analysis
The Penicillin/Streptomycin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Penicillin/Streptomycin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Penicillin/Streptomycin Market Share Analysis
Penicillin/Streptomycin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Penicillin/Streptomycin business, the date to enter into the Penicillin/Streptomycin market, Penicillin/Streptomycin product introduction, recent developments, etc.

The major vendors covered:
Johnson & Johnson
Pfizer
Bayer HealthCare
Abbot Laboratories
Roche Pharmaceuticals
Sanofi Aventis
Takeda Pharmaceutical Company
Toyama Chemical
Merck & Co.
MiddleBrook Pharmaceuticals
Novartis
Biogen IDEC
Bristol Myers Squibb
Celgine Corporation
Eli Lilly and Co
Gilead Sciences
GlaxoSmithKline
Amgen
Astellas Pharma
Astra Zeneca

【レポートの目次】

1 Study Coverage
1.1 Penicillin/Streptomycin Product Introduction
1.2 Market Segments
1.3 Key Penicillin/Streptomycin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Penicillin/Streptomycin Market Size Growth Rate by Type
1.4.2 Penicillin
1.4.3 Streptomycin
1.5 Market by Application
1.5.1 Global Penicillin/Streptomycin Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Penicillin/Streptomycin Market Size, Estimates and Forecasts
2.1.1 Global Penicillin/Streptomycin Revenue 2015-2026
2.1.2 Global Penicillin/Streptomycin Sales 2015-2026
2.2 Global Penicillin/Streptomycin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Penicillin/Streptomycin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Penicillin/Streptomycin Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Penicillin/Streptomycin Competitor Landscape by Players
3.1 Penicillin/Streptomycin Sales by Manufacturers
3.1.1 Penicillin/Streptomycin Sales by Manufacturers (2015-2020)
3.1.2 Penicillin/Streptomycin Sales Market Share by Manufacturers (2015-2020)
3.2 Penicillin/Streptomycin Revenue by Manufacturers
3.2.1 Penicillin/Streptomycin Revenue by Manufacturers (2015-2020)
3.2.2 Penicillin/Streptomycin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Penicillin/Streptomycin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Penicillin/Streptomycin Revenue in 2019
3.2.5 Global Penicillin/Streptomycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Penicillin/Streptomycin Price by Manufacturers
3.4 Penicillin/Streptomycin Manufacturing Base Distribution, Product Types
3.4.1 Penicillin/Streptomycin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Penicillin/Streptomycin Product Type
3.4.3 Date of International Manufacturers Enter into Penicillin/Streptomycin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Penicillin/Streptomycin Market Size by Type (2015-2020)
4.1.1 Global Penicillin/Streptomycin Sales by Type (2015-2020)
4.1.2 Global Penicillin/Streptomycin Revenue by Type (2015-2020)
4.1.3 Penicillin/Streptomycin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Penicillin/Streptomycin Market Size Forecast by Type (2021-2026)
4.2.1 Global Penicillin/Streptomycin Sales Forecast by Type (2021-2026)
4.2.2 Global Penicillin/Streptomycin Revenue Forecast by Type (2021-2026)
4.2.3 Penicillin/Streptomycin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Penicillin/Streptomycin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Penicillin/Streptomycin Market Size by Application (2015-2020)
5.1.1 Global Penicillin/Streptomycin Sales by Application (2015-2020)
5.1.2 Global Penicillin/Streptomycin Revenue by Application (2015-2020)
5.1.3 Penicillin/Streptomycin Price by Application (2015-2020)
5.2 Penicillin/Streptomycin Market Size Forecast by Application (2021-2026)
5.2.1 Global Penicillin/Streptomycin Sales Forecast by Application (2021-2026)
5.2.2 Global Penicillin/Streptomycin Revenue Forecast by Application (2021-2026)
5.2.3 Global Penicillin/Streptomycin Price Forecast by Application (2021-2026)

6 North America
6.1 North America Penicillin/Streptomycin by Country
6.1.1 North America Penicillin/Streptomycin Sales by Country
6.1.2 North America Penicillin/Streptomycin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Penicillin/Streptomycin Market Facts & Figures by Type
6.3 North America Penicillin/Streptomycin Market Facts & Figures by Application

7 Europe
7.1 Europe Penicillin/Streptomycin by Country
7.1.1 Europe Penicillin/Streptomycin Sales by Country
7.1.2 Europe Penicillin/Streptomycin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Penicillin/Streptomycin Market Facts & Figures by Type
7.3 Europe Penicillin/Streptomycin Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Penicillin/Streptomycin by Region
8.1.1 Asia Pacific Penicillin/Streptomycin Sales by Region
8.1.2 Asia Pacific Penicillin/Streptomycin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Penicillin/Streptomycin Market Facts & Figures by Type
8.3 Asia Pacific Penicillin/Streptomycin Market Facts & Figures by Application

9 Latin America
9.1 Latin America Penicillin/Streptomycin by Country
9.1.1 Latin America Penicillin/Streptomycin Sales by Country
9.1.2 Latin America Penicillin/Streptomycin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Penicillin/Streptomycin Market Facts & Figures by Type
9.3 Central & South America Penicillin/Streptomycin Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Penicillin/Streptomycin by Country
10.1.1 Middle East and Africa Penicillin/Streptomycin Sales by Country
10.1.2 Middle East and Africa Penicillin/Streptomycin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Penicillin/Streptomycin Market Facts & Figures by Type
10.3 Middle East and Africa Penicillin/Streptomycin Market Facts & Figures by Application

11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Penicillin/Streptomycin Products Offered
11.1.5 Johnson & Johnson Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Penicillin/Streptomycin Products Offered
11.2.5 Pfizer Related Developments
11.3 Bayer HealthCare
11.3.1 Bayer HealthCare Corporation Information
11.3.2 Bayer HealthCare Description and Business Overview
11.3.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer HealthCare Penicillin/Streptomycin Products Offered
11.3.5 Bayer HealthCare Related Developments
11.4 Abbot Laboratories
11.4.1 Abbot Laboratories Corporation Information
11.4.2 Abbot Laboratories Description and Business Overview
11.4.3 Abbot Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abbot Laboratories Penicillin/Streptomycin Products Offered
11.4.5 Abbot Laboratories Related Developments
11.5 Roche Pharmaceuticals
11.5.1 Roche Pharmaceuticals Corporation Information
11.5.2 Roche Pharmaceuticals Description and Business Overview
11.5.3 Roche Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Roche Pharmaceuticals Penicillin/Streptomycin Products Offered
11.5.5 Roche Pharmaceuticals Related Developments
11.6 Sanofi Aventis
11.6.1 Sanofi Aventis Corporation Information
11.6.2 Sanofi Aventis Description and Business Overview
11.6.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Aventis Penicillin/Streptomycin Products Offered
11.6.5 Sanofi Aventis Related Developments
11.7 Takeda Pharmaceutical Company
11.7.1 Takeda Pharmaceutical Company Corporation Information
11.7.2 Takeda Pharmaceutical Company Description and Business Overview
11.7.3 Takeda Pharmaceutical Company Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Takeda Pharmaceutical Company Penicillin/Streptomycin Products Offered
11.7.5 Takeda Pharmaceutical Company Related Developments
11.8 Toyama Chemical
11.8.1 Toyama Chemical Corporation Information
11.8.2 Toyama Chemical Description and Business Overview
11.8.3 Toyama Chemical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Toyama Chemical Penicillin/Streptomycin Products Offered
11.8.5 Toyama Chemical Related Developments
11.9 Merck & Co.
11.9.1 Merck & Co. Corporation Information
11.9.2 Merck & Co. Description and Business Overview
11.9.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck & Co. Penicillin/Streptomycin Products Offered
11.9.5 Merck & Co. Related Developments
11.10 MiddleBrook Pharmaceuticals
11.10.1 MiddleBrook Pharmaceuticals Corporation Information
11.10.2 MiddleBrook Pharmaceuticals Description and Business Overview
11.10.3 MiddleBrook Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 MiddleBrook Pharmaceuticals Penicillin/Streptomycin Products Offered
11.10.5 MiddleBrook Pharmaceuticals Related Developments
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Penicillin/Streptomycin Products Offered
11.1.5 Johnson & Johnson Related Developments
11.12 Biogen IDEC
11.12.1 Biogen IDEC Corporation Information
11.12.2 Biogen IDEC Description and Business Overview
11.12.3 Biogen IDEC Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Biogen IDEC Products Offered
11.12.5 Biogen IDEC Related Developments
11.13 Bristol Myers Squibb
11.13.1 Bristol Myers Squibb Corporation Information
11.13.2 Bristol Myers Squibb Description and Business Overview
11.13.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Bristol Myers Squibb Products Offered
11.13.5 Bristol Myers Squibb Related Developments
11.14 Celgine Corporation
11.14.1 Celgine Corporation Corporation Information
11.14.2 Celgine Corporation Description and Business Overview
11.14.3 Celgine Corporation Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Celgine Corporation Products Offered
11.14.5 Celgine Corporation Related Developments
11.15 Eli Lilly and Co
11.15.1 Eli Lilly and Co Corporation Information
11.15.2 Eli Lilly and Co Description and Business Overview
11.15.3 Eli Lilly and Co Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Eli Lilly and Co Products Offered
11.15.5 Eli Lilly and Co Related Developments
11.16 Gilead Sciences
11.16.1 Gilead Sciences Corporation Information
11.16.2 Gilead Sciences Description and Business Overview
11.16.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Gilead Sciences Products Offered
11.16.5 Gilead Sciences Related Developments
11.17 GlaxoSmithKline
11.17.1 GlaxoSmithKline Corporation Information
11.17.2 GlaxoSmithKline Description and Business Overview
11.17.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.17.4 GlaxoSmithKline Products Offered
11.17.5 GlaxoSmithKline Related Developments
11.18 Amgen
11.18.1 Amgen Corporation Information
11.18.2 Amgen Description and Business Overview
11.18.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Amgen Products Offered
11.18.5 Amgen Related Developments
11.19 Astellas Pharma
11.19.1 Astellas Pharma Corporation Information
11.19.2 Astellas Pharma Description and Business Overview
11.19.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Astellas Pharma Products Offered
11.19.5 Astellas Pharma Related Developments
11.20 Astra Zeneca
11.20.1 Astra Zeneca Corporation Information
11.20.2 Astra Zeneca Description and Business Overview
11.20.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Astra Zeneca Products Offered
11.20.5 Astra Zeneca Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Penicillin/Streptomycin Market Estimates and Projections by Region
12.1.1 Global Penicillin/Streptomycin Sales Forecast by Regions 2021-2026
12.1.2 Global Penicillin/Streptomycin Revenue Forecast by Regions 2021-2026
12.2 North America Penicillin/Streptomycin Market Size Forecast (2021-2026)
12.2.1 North America: Penicillin/Streptomycin Sales Forecast (2021-2026)
12.2.2 North America: Penicillin/Streptomycin Revenue Forecast (2021-2026)
12.2.3 North America: Penicillin/Streptomycin Market Size Forecast by Country (2021-2026)
12.3 Europe Penicillin/Streptomycin Market Size Forecast (2021-2026)
12.3.1 Europe: Penicillin/Streptomycin Sales Forecast (2021-2026)
12.3.2 Europe: Penicillin/Streptomycin Revenue Forecast (2021-2026)
12.3.3 Europe: Penicillin/Streptomycin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Penicillin/Streptomycin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Penicillin/Streptomycin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Penicillin/Streptomycin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Penicillin/Streptomycin Market Size Forecast by Region (2021-2026)
12.5 Latin America Penicillin/Streptomycin Market Size Forecast (2021-2026)
12.5.1 Latin America: Penicillin/Streptomycin Sales Forecast (2021-2026)
12.5.2 Latin America: Penicillin/Streptomycin Revenue Forecast (2021-2026)
12.5.3 Latin America: Penicillin/Streptomycin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Penicillin/Streptomycin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Penicillin/Streptomycin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Penicillin/Streptomycin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Penicillin/Streptomycin Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Penicillin/Streptomycin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Penicillin/Streptomycin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Johnson & Johnson、Pfizer、Bayer HealthCare、Abbot Laboratories、Roche Pharmaceuticals、Sanofi Aventis、Takeda Pharmaceutical Company、Toyama Chemical、Merck & Co.、MiddleBrook Pharmaceuticals、Novartis、Biogen IDEC、Bristol Myers Squibb、Celgine Corporation、Eli Lilly and Co、Gilead Sciences、GlaxoSmithKline、Amgen、Astellas Pharma、Astra Zeneca

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のペニシリン/ストレプトマイシン市場2026:インサイト・予測(Global Penicillin/Streptomycin Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。